Metagenomics Market 2021-2026: Size, Share, Analysis, Key players and Outlook

According to the latest report by IMARC Group, titled “Metagenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026”, offers a comprehensive analysis of the industry, which comprises insights on metagenomics market analysis. The report also includes competitor and regional analysis, and contemporary advancements in the global market. The global metagenomics market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026. Metagenomics refers to the study of microbial genomes in their natural environment. It involves cloning of genome to study evolution, ecology, diversity, etc., thereby bypassing the requirement for isolation and laboratory cultivation of individual species. Metagenomics assists in gaining scientific insights utilizing sequencing and bioinformatics technologies and is used as a molecular tool to analyze the deoxyribonucleic acid (DNA) acquired from the environmental samples through soil, water, and human waste. These samples are further processed by sequence reading, gene prediction, binning, functional annotation, etc. The insights are useful for diagnosing infectious diseases, gut microbe characterization, environmental remediation, developing biofuels, etc.

We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Request Free Sample Report: https://www.imarcgroup.com/metagenomics-market/requestsample

Metagenomics Market Trends:

The rising prevalence of numerous infectious diseases, including diarrhea, hepatitis B, HIV/AIDS, etc., is one of the primary factors driving the metagenomics market. Moreover, the escalating demand for effective solutions for the timely diagnosis of neuroinfectious ailments, such as encephalitis and meningitis, is further bolstering the market growth. Additionally, metagenomics is also gaining traction for identifying bacterial pathogens causing foodborne disease outbreaks. Compared to conventionally used technologies, metagenomics needs fewer pre-sequencing steps, offers greater authenticity of long readings, provides high read accuracy, etc. Furthermore, various technological developments, including the integration of next-generation sequencing services with data analysis software for faster analysis and sample processing, will continue to catalyze the global metagenomics market growth over the forecasted period.

Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/metagenomics-market

Key Market Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Some of these key players include:

Agilent Technologies Inc
Enterome
Eurofins Scientific
Hoffmann-La Roche AG (Roche Holding AG)
Illumina Inc, Novogene Co. Ltd.
Oxford Nanopore Technologies Limited
Pacific Biosciences of California Inc.
PerkinElmer Inc.
QIAGEN N.V.
Swift Biosciences Inc. (Danaher Corporation)
Thermo Fisher Scientific Inc.

Breakup by Product:

Instruments and Software
Consumables

Breakup by Technology:

Sequencing
Bioinformatics

Breakup by Application:

Infectious Disease Diagnosis
Environmental Remediation
Gut Microbe Characterization
Biotechnology
Biofuel
Agriculture

Breakup by Region:

Middle East and Africa
North America
Asia-Pacific
Europe
Latin America

Key highlights of the Report:

Market Performance (2015-2020)
Market Outlook (2021-2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
SWOT Analysis
Value Chain
Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact US

IMARC Group

30 N Gould St Ste R
Sheridan, WY 82801 USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Enjoyed this article? Stay informed by joining our newsletter!